Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.

Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, Rouleau JL, Shi V, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV.

JACC Heart Fail. 2019 Jun;7(6):457-465. doi: 10.1016/j.jchf.2019.02.015. Epub 2019 May 8.

2.

Improving recruitment for clinical trials: the human touch.

Jhund PS.

Med J Aust. 2019 May;210(9):401-402. doi: 10.5694/mja2.50161. Epub 2019 May 8. No abstract available.

PMID:
31069806
3.

Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.

Shen L, Jhund PS, Docherty KF, Petrie MC, Anand IS, Carson PE, Desai AS, Granger CB, Komajda M, McKelvie RS, Pfeffer MA, Solomon SD, Swedberg K, Zile MR, McMurray JJV.

JACC Heart Fail. 2019 May;7(5):418-427. doi: 10.1016/j.jchf.2018.12.006. Epub 2019 Apr 10.

PMID:
30981744
4.

"Real World" Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry.

Simpson J, Benson L, Jhund PS, Dahlström U, McMurray JJV, Lund LH.

Cardiovasc Drugs Ther. 2019 Jun;33(3):315-322. doi: 10.1007/s10557-019-06873-1.

5.

N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.

Kristensen SL, Mogensen UM, Jhund PS, Rørth R, Anand IS, Carson PE, Desai AS, Pitt B, Pfeffer MA, Solomon SD, Zile MR, Køber L, McMurray JJV.

Circ Heart Fail. 2019 Mar;12(3):e005766. doi: 10.1161/CIRCHEARTFAILURE.118.005766.

PMID:
30871349
6.

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis.

Dewan P, Rørth R, Jhund PS, Ferreira JP, Zannad F, Shen L, Køber L, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators.

JACC Heart Fail. 2019 Apr;7(4):336-346. doi: 10.1016/j.jchf.2018.11.005. Epub 2019 Feb 6.

7.

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction.

Rørth R, Dewan P, Kristensen SL, Jhund PS, Petrie MC, Køber L, McMurray JJV.

Clin Res Cardiol. 2019 Jan 28. doi: 10.1007/s00392-019-01415-z. [Epub ahead of print]

PMID:
30689020
8.

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women.

Dewan P, Rørth R, Jhund PS, Shen L, Raparelli V, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Mogensen UM, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV.

J Am Coll Cardiol. 2019 Jan 8;73(1):29-40. doi: 10.1016/j.jacc.2018.09.081.

9.

The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.

Rørth R, Jhund PS, Kristensen SL, Desai AS, Køber L, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV.

Eur J Heart Fail. 2019 Jan;21(1):40-49. doi: 10.1002/ejhf.1359. Epub 2018 Dec 10.

PMID:
30537261
10.

Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.

Dewan P, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Køber L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS Jr, Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV.

Eur J Heart Fail. 2019 May;21(5):577-587. doi: 10.1002/ejhf.1347. Epub 2018 Dec 10.

PMID:
30536678
11.

Contemporary Management of Heart Failure in the Elderly.

Osmanska J, Jhund PS.

Drugs Aging. 2019 Feb;36(2):137-146. doi: 10.1007/s40266-018-0625-4. Review.

PMID:
30535931
12.

Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA.

Beggs SAS, Jhund PS, McMurray JJV.

Eur Heart J. 2018 Oct 23. doi: 10.1093/eurheartj/ehy609. [Epub ahead of print] No abstract available.

PMID:
30357375
13.

Diabetic cardiomyopathy.

Lee MMY, McMurray JJV, Lorenzo-Almorós A, Kristensen SL, Sattar N, Jhund PS, Petrie MC.

Heart. 2018 Oct 18. pii: heartjnl-2016-310342. doi: 10.1136/heartjnl-2016-310342. [Epub ahead of print] No abstract available.

PMID:
30337334
14.

Initiation of domiciliary care and nursing home admission following first hospitalization of heart failure patients: a nationwide cohort study.

Rørth R, Fosbøl EL, Kragholm K, Mogensen UM, Jhund PS, Petrie MC, Torp-Pedersen C, Gislason GH, McMurray JJ, Køber L, Kristensen SL.

Clin Epidemiol. 2018 Aug 2;10:917-930. doi: 10.2147/CLEP.S164795. eCollection 2018.

15.

Association is not causation: treatment effects cannot be estimated from observational data in heart failure.

Rush CJ, Campbell RT, Jhund PS, Petrie MC, McMurray JJV.

Eur Heart J. 2018 Oct 1;39(37):3417-3438. doi: 10.1093/eurheartj/ehy407.

16.

Catheter Ablation for Atrial Fibrillation with Heart Failure.

Docherty KF, Jhund PS, McMurray JJV.

N Engl J Med. 2018 Aug 2;379(5):491-2. doi: 10.1056/NEJMc1806519. No abstract available.

PMID:
30070094
17.

Which patients with heart failure should receive specialist palliative care?

Campbell RT, Petrie MC, Jackson CE, Jhund PS, Wright A, Gardner RS, Sonecki P, Pozzi A, McSkimming P, McConnachie A, Finlay F, Davidson P, Denvir MA, Johnson MJ, Hogg KJ, McMurray JJV.

Eur J Heart Fail. 2018 Sep;20(9):1338-1347. doi: 10.1002/ejhf.1240. Epub 2018 Jun 28.

PMID:
29952090
18.

Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early?

Docherty KF, Jhund PS.

Heart. 2018 Nov;104(22):1812-1813. doi: 10.1136/heartjnl-2018-313371. Epub 2018 May 14. No abstract available.

PMID:
29760244
19.

Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial.

Kristensen SL, Rørth R, Jhund PS, Shen L, Lee MMY, Petrie MC, Køber L, McMurray JJV; BEST Investigators.

Eur J Heart Fail. 2018 Nov;20(11):1549-1556. doi: 10.1002/ejhf.1201. Epub 2018 May 4.

PMID:
29727039
20.

Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK Biobank.

Welsh C, Welsh P, Mark PB, Celis-Morales CA, Lewsey J, Gray SR, Lyall DM, Iliodromiti S, Gill JMR, Pell J, Jhund PS, Sattar N.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1415-1423. doi: 10.1161/ATVBAHA.118.310945. Epub 2018 Apr 26.

PMID:
29699973
21.

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.

Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray JJV.

JACC Heart Fail. 2018 Jun;6(6):489-498. doi: 10.1016/j.jchf.2018.02.004. Epub 2018 Apr 11.

22.

Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction.

Rørth R, Jhund PS, Mogensen UM, Kristensen SL, Petrie MC, Køber L, McMurray JJV.

Diabetes Care. 2018 Jun;41(6):1285-1291. doi: 10.2337/dc17-2583. Epub 2018 Apr 6.

PMID:
29626073
23.

Analysing registries in heart failure: The case of angiotensin receptor blockers in Asians with heart failure with reduced ejection fraction.

Jhund PS.

Int J Cardiol. 2018 Apr 15;257:224-225. doi: 10.1016/j.ijcard.2018.01.061. No abstract available.

PMID:
29506698
24.

Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.

Abdul-Rahim AH, Shen L, Rush CJ, Jhund PS, Lees KR, McMurray JJV; VICCTA-Heart Failure Collaborators.

Eur J Heart Fail. 2018 Jul;20(7):1139-1145. doi: 10.1002/ejhf.1160. Epub 2018 Mar 1.

PMID:
29493058
25.

Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.

Cosmi F, Shen L, Magnoli M, Abraham WT, Anand IS, Cleland JG, Cohn JN, Cosmi D, De Berardis G, Dickstein K, Franzosi MG, Gullestad L, Jhund PS, Kjekshus J, Køber L, Lepore V, Lucisano G, Maggioni AP, Masson S, McMurray JJV, Nicolucci A, Petrarolo V, Robusto F, Staszewsky L, Tavazzi L, Teli R, Tognoni G, Wikstrand J, Latini R.

Eur J Heart Fail. 2018 May;20(5):888-895. doi: 10.1002/ejhf.1146. Epub 2018 Feb 28.

26.

Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.

Lund LH, Claggett B, Liu J, Lam CS, Jhund PS, Rosano GM, Swedberg K, Yusuf S, Granger CB, Pfeffer MA, McMurray JJV, Solomon SD.

Eur J Heart Fail. 2018 Aug;20(8):1230-1239. doi: 10.1002/ejhf.1149. Epub 2018 Feb 12.

PMID:
29431256
27.

Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

Mogensen UM, Gong J, Jhund PS, Shen L, Køber L, Desai AS, Lefkowitz MP, Packer M, Rouleau JL, Solomon SD, Claggett BL, Swedberg K, Zile MR, Mueller-Velten G, McMurray JJV.

Eur J Heart Fail. 2018 Apr;20(4):760-768. doi: 10.1002/ejhf.1139. Epub 2018 Feb 12.

28.

Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure.

Rørth R, Fosbøl EL, Mogensen UM, Kragholm K, Jhund PS, Petrie MC, Schou M, Gislason GH, McMurray JJV, Torp-Pedersen C, Køber L, Kristensen SL.

JACC Heart Fail. 2018 Jan;6(1):41-48. doi: 10.1016/j.jchf.2017.09.019. Epub 2017 Dec 6.

29.

Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF.

Mogensen UM, Køber L, Jhund PS, Desai AS, Senni M, Kristensen SL, Dukát A, Chen CH, Ramires F, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Solomon SD, Swedberg K, Packer M, McMurray JJV; PARADIGM-HF Investigators and Committees.

Eur J Heart Fail. 2018 Mar;20(3):514-522. doi: 10.1002/ejhf.1056. Epub 2017 Nov 30.

30.

Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure.

Rørth R, Fosbøl EL, Mogensen UM, Kragholm K, Numé AK, Gislason GH, Jhund PS, Petrie MC, McMurray JJV, Torp-Pedersen C, Køber L, Kristensen SL.

Eur J Heart Fail. 2018 Feb;20(2):240-247. doi: 10.1002/ejhf.1046. Epub 2017 Nov 16.

31.

Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.

Mogensen UM, Jhund PS, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Køber L, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators and Committees.

J Am Coll Cardiol. 2017 Nov 14;70(20):2490-2500. doi: 10.1016/j.jacc.2017.09.027.

32.

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.

Shen L, Ramires F, Martinez F, Bodanese LC, Echeverría LE, Gómez EA, Abraham WT, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, Gimpelewicz CR, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators and Committees.

Circ Heart Fail. 2017 Nov;10(11). pii: e004361. doi: 10.1161/CIRCHEARTFAILURE.117.004361.

PMID:
29141857
33.

Peripartum cardiomyopathy: diagnosis and management.

Jackson AM, Dalzell JR, Walker NL, Coats CJ, Jhund PS, Petrie MC.

Heart. 2018 May;104(9):779-786. doi: 10.1136/heartjnl-2016-310599. Epub 2017 Nov 9. No abstract available.

PMID:
29122930
34.

Declining Risk of Sudden Death in Heart Failure.

Shen L, Jhund PS, McMurray JJV.

N Engl J Med. 2017 Nov 2;377(18):1794-5. doi: 10.1056/NEJMc1711901. No abstract available.

PMID:
29091558
35.

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.

Kristensen SL, Jhund PS, Mogensen UM, Rørth R, Abraham WT, Desai A, Dickstein K, Rouleau JL, Zile MR, Swedberg K, Packer M, Solomon SD, Køber L, McMurray JJV; PARADIGM-HF and ATMOSPHERE Committees and Investigators.

Circ Heart Fail. 2017 Oct;10(10). pii: e004409. doi: 10.1161/CIRCHEARTFAILURE.117.004409.

PMID:
29018174
36.

Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.

Beggs SAS, Jhund PS, Jackson CE, McMurray JJV, Gardner RS.

Heart. 2018 Jan;104(2):144-150. doi: 10.1136/heartjnl-2016-310850. Epub 2017 Oct 6.

PMID:
28986406
37.

Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial.

Kristensen SL, Mogensen UM, Tarnesby G, Gimpelewicz CR, Ali MA, Shao Q, Chiang Y, Jhund PS, Abraham WT, Dickstein K, McMurray JJV, Køber L.

Eur J Heart Fail. 2018 Jan;20(1):136-147. doi: 10.1002/ejhf.896. Epub 2017 Sep 25.

38.

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes.

Kristensen SL, Jhund PS, Lee MMY, Køber L, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, McMurray JJV; CHARM Investigators and Committees.

Cardiovasc Drugs Ther. 2017 Dec;31(5-6):545-549. doi: 10.1007/s10557-017-6754-x.

39.

Heart Failure in Young Adults Is Associated With High Mortality: A Contemporary Population-Level Analysis.

Wong CM, Hawkins NM, Ezekowitz JA, Jhund PS, Savu A, MacDonald MR, Kristensen SL, Petrie MC, McMurray JJV, McAlister FA, Kaul P.

Can J Cardiol. 2017 Nov;33(11):1472-1477. doi: 10.1016/j.cjca.2017.05.009. Epub 2017 Jun 19.

PMID:
28941947
40.

Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality.

Platz E, Jhund PS, Claggett BL, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, McMurray JJ.

Eur J Heart Fail. 2018 Feb;20(2):295-303. doi: 10.1002/ejhf.901. Epub 2017 Sep 4.

41.

Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits.

Shen L, Jhund PS, Mogensen UM, Køber L, Claggett B, Rogers JK, McMurray JJV.

JACC Heart Fail. 2017 Aug;5(8):591-599. doi: 10.1016/j.jchf.2017.04.005.

42.

Declining Risk of Sudden Death in Heart Failure.

Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, Dargie HJ, Granger CB, Kjekshus J, Køber L, Latini R, Maggioni AP, Packer M, Pitt B, Solomon SD, Swedberg K, Tavazzi L, Wikstrand J, Zannad F, Zile MR, McMurray JJV.

N Engl J Med. 2017 Jul 6;377(1):41-51. doi: 10.1056/NEJMoa1609758.

43.

The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.

Mogensen UM, Køber L, Kristensen SL, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJV; PARADIGM-HF Investigators and Committees.

Am Heart J. 2017 Jun;188:35-41. doi: 10.1016/j.ahj.2017.02.034. Epub 2017 Mar 14.

PMID:
28577679
44.

Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review.

Platz E, Merz AA, Jhund PS, Vazir A, Campbell R, McMurray JJ.

Eur J Heart Fail. 2017 Sep;19(9):1154-1163. doi: 10.1002/ejhf.839. Epub 2017 May 30. Review.

45.

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.

Abdul-Rahim AH, Perez AC, MacIsaac RL, Jhund PS, Claggett BL, Carson PE, Komajda M, McKelvie RS, Zile MR, Swedberg K, Yusuf S, Pfeffer MA, Solomon SD, Lip GYH, Lees KR, McMurray JJV; Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved (CHARM-Preserved) and the Irbesartan in Heart Failure with Preserved Systolic Function (I-Preserve) Steering Committees.

Eur Heart J. 2017 Mar 7;38(10):742-750. doi: 10.1093/eurheartj/ehw509. Erratum in: Eur Heart J. 2018 Apr 21;39(16):1403.

46.

Obesity and heart failure: when 'epidemics' collide.

Jhund PS.

Eur Heart J. 2017 Jun 21;38(24):1934-1936. doi: 10.1093/eurheartj/ehw357. No abstract available.

PMID:
28369264
47.

Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.

Böhm M, Young R, Jhund PS, Solomon SD, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Packer M, McMurray JJV.

Eur Heart J. 2017 Apr 14;38(15):1132-1143. doi: 10.1093/eurheartj/ehw570.

48.

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).

Kristensen SL, Mogensen UM, Jhund PS, Petrie MC, Preiss D, Win S, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Gottdiener JS, Carson PE, McMurray JJ.

Circulation. 2017 Feb 21;135(8):724-735. doi: 10.1161/CIRCULATIONAHA.116.024593. Epub 2017 Jan 4.

PMID:
28052977
49.

Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.

Cannon JA, Shen L, Jhund PS, Kristensen SL, Køber L, Chen F, Gong J, Lefkowitz MP, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJ; PARADIGM-HF Investigators and Committees.

Eur J Heart Fail. 2017 Jan;19(1):129-137. doi: 10.1002/ejhf.687. Epub 2016 Nov 20.

50.

Geographic variation in heart failure-a matter of celebration or condemnation?

Jhund PS.

Eur J Heart Fail. 2016 Nov;18(11):1329-1330. doi: 10.1002/ejhf.652. No abstract available.

Supplemental Content

Loading ...
Support Center